MT
TEVA icon

Midwest Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Midwest Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Sell
48,636
-1,877
-4% -$62.5K 0.02% 317
2026
Q1 		$1.52M Sell
50,513
-882
-2% -$28.4K 0.02% 315
2025
Q4 		$1.6M Sell
51,395
-1,844
-3% -$45.4K 0.02% 303
2025
Q3 		$1.08M Sell
53,239
-17,171
-24% -$302K 0.01% 337
2025
Q2 		$1.18M Buy
+70,410
New +$1.14M 0.02% 322

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Midwest Trust's TEVA Position: Q2 2026 in Review

Midwest Trust reduced its Teva Pharmaceuticals (TEVA) stake by 3.7% in Q2 2026, selling an estimated $62.5K and leaving 48,636 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #317.

Midwest Trust first reported a position in TEVA in Q2 2025 and has held it in 5 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Midwest Trust held 48,636 shares of Teva Pharmaceuticals worth $1.65M as of Q2 2026.
  • Midwest Trust sold 1,877 Teva Pharmaceuticals shares in Q2 2026, an estimated $62.5K.
  • Teva Pharmaceuticals made up 0.02% of Midwest Trust's portfolio in Q2 2026, its #317 holding.
  • Midwest Trust first reported a position in Teva Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.